Litigating patents in investment arbitration: Eli Lilly v Canada

  • Lentner G
N/ACitations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Abstract

For the first time in investment arbitration, a tribunal has ruled in a case involving the invalidation of a pharmaceutical company's patents by Canadian courts in an investment-based claim.

Cite

CITATION STYLE

APA

Lentner, G. M. (2017). Litigating patents in investment arbitration: Eli Lilly v Canada. Journal of Intellectual Property Law & Practice, 12(10), 815–816. https://doi.org/10.1093/jiplp/jpx153

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free